Promomed (PRMD) EV/EBITDA MSFO (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 0.88 | 1.52 | 2.48 | 11.2 | 7.07 | 6.63 | ||
| Changes by years, y/y, % | +73% | +64% | +350% | -37% | +68.5% | ||||
Promomed. EV/EBITDA
Promomed. EV/EBITDA, changes, %
Promomed (PRMD) EV/EBITDA MSFO (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q4 | 2026Q1 | 2026Q2 | LTM ? | |||
| EV/EBITDA | ? | 11.1 | 10.5 | 7.07 | 5.73 | 7.58 | 6.63 | |
| Changes by years, y/y, % | +395% | +409% | -37% | -48% | -28% | |||
| Changes by quarters, q/q, % | -1% | -5% | -33% | -19% | +32% | |||